#007: The IPO Freeze, Tariff Volatility, Peak Private Valuations, and Colossal Biosciences
The IPO freeze is here. Craig unpacks the impact of tariff volatility on the IPO markets. It’s not good, at least for the time being. He also explores the possibility…